Melatonin level and risk for type 2 diabetes - In reply

JAMA

Volumn 310, Issue 5, 2013, Pages 537-

  McMullan, Ciaran J ^a   Schernhammer, Eva S ^a   Forman, John P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

BODY MASS; CARDIOVASCULAR RISK; CIRCADIAN MISALIGNMENT; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; GLUCOSE METABOLISM; HORMONE RELEASE; HORMONE URINE LEVEL; HUMAN; LETTER; NIGHT WORK; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RISK FACTOR; SHIFT WORKER;

EID: 84881244874     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.7655     Document Type: Letter

References (3)

1. Schernhammer ES, Kroenke CH, Dowsett M, Folkerd E, Hankinson SE. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. J Pineal Res. 2006;40(2):116-124.
2. Schernhammer ES, Rosner B, Willett WC, Laden F, Colditz GA, Hankinson SE. Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol Biomarkers Prev. 2004;13(6):936-943. (Pubitemid 38756703)
3. Kroenke CH, Spiegelman D, Manson J, Schernhammer ES, Colditz GA, Kawachi I. Work characteristics and incidence of type 2 diabetes in women. Am J Epidemiol. 2007;165(2):175-183. (Pubitemid 46096379)